Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
This study aims to institute a province-wide registry leveraging the availability of a new Positron Emission Tomography tracer, [18F]-DCFPyL and PET expertise across Ontario centers to improve our ability to characterize patterns of recurrence and personalize therapies in men with recurrent prostate cancer after primary treatment.
Sponsor:
Lawson Health Research Institute
Contacts:
Catherine Hildebrand, PhD (Project Coordinator)catherine.hildebrand@lhsc.on.ca
519-685-8500 ext 53535
Government Study Link:
NCT03718260 - Click here to see study onClinicalTrials.gov
Help us improve your experience